KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Change in Cash (2016 - 2025)

Merck (MRK) has disclosed Change in Cash for 17 consecutive years, with -$3.6 billion as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 160.58% to -$3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, down 78.59% year-over-year, with the annual reading at $1.4 billion for FY2025, 78.59% down from the prior year.
  • Change in Cash for Q4 2025 was -$3.6 billion at Merck, down from $10.2 billion in the prior quarter.
  • The five-year high for Change in Cash was $10.2 billion in Q3 2025, with the low at -$4.6 billion in Q1 2025.
  • Average Change in Cash over 5 years is $326.8 million, with a median of -$106.0 million recorded in 2022.
  • The sharpest move saw Change in Cash crashed 768.23% in 2023, then soared 239.96% in 2024.
  • Over 5 years, Change in Cash stood at -$1.9 billion in 2021, then skyrocketed by 179.51% to $1.5 billion in 2022, then crashed by 217.8% to -$1.8 billion in 2023, then grew by 22.16% to -$1.4 billion in 2024, then crashed by 160.58% to -$3.6 billion in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$3.6 billion, $10.2 billion, and -$659.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.